IUD Taskforce

About The Taskforce

The NYC LARC Access Taskforce aims to ensure that everyone has access to a full range of contraceptive methods, including highly effective long-acting reversible contraceptives (LARCs). 

LARCs are highly effective and safe contraception options that can be removed when no longer desired. The Taskforce seeks to address the systemic barriers (financial, institutional, legal, and educational) that may limit knowledge, awareness, access, and use of LARCs, specifically IUDs and implants. 

The Taskforce launched in January 2013 in response to a need expressed by the family planning provider community in New York City to share information, resources, and strategy. It is the first municipal-level taskforce working to facilitate city-wide, multidisciplinary coordination around IUD access. The LARC Access Taskforce’s newest project is the online LARC Community of Practice.  A community of practice is a group of professionals that shares information, resources, and lessons learned about a specific topic.

LARC Access Taskforce Goals

The LARC Access Taskforce aims to create an environment that ensures that everyone has access to a full-range of contraceptive options, including the highly effective methods (IUDs and implants). The Taskforce aims to improve institutional and community readiness* by understanding and challenging obstacles to LARC usage at the individual (patient/healthcare provider), institutional, community, and policy levels.

*Community readiness refers to the degree a community and its institutions are prepared to take action on an issue.  Learn more about Community Readiness here.

The Taskforce:

  • Facilitates productive and sustained coordination and dialogue surrounding IUD-related issues among health care providers, health professionals, educators, administrators, researchers, legal and community advocates, and other relevant stakeholders in New York City.
  • Advocates for dual-protection to prevent sexually transmitted infections and unintended pregnancy, effective counseling for all patients interested in using LARC methods, and the support to determine which method(s) are right for them.
  • Maintains the online LARC Community of Practice to facilitate coordination, collaboration, knowledge exchange, resource development, training, and dissemination of IUD research, resources, and news.

Why LARCs

The LARC Access Taskforce has chosen to focus specifically on LARCs due to their consistently low rates of use among American women using contraceptives, despite their clinical effectiveness,[i] superior ease of use as “forgettable” contraceptives that do not require daily action by the user,[ii]  and demonstrated success in reducing unintended pregnancy.[iii] Despite our focus on long-acting reversible contraception, the Taskforce defines its scope of work to include the full range of contraception, recognizing that many of the same barriers apply to other contraceptive methods. It is integral to our mission to ensure all people have the information and resources they need to make informed decisions about contraception.

Taskforce Membership and Structure

  • More than 60 medical providers, educators, administrators, public health professionals, reproductive health advocates, and researchers from more than 25 New York City-based organizations currently serve on the LARC Taskforce. 
  • The LARC Taskforce’s central activities are concentrated in the Taskforce workgroups, comprised of voluntary members that meet regularly. 
  • Efforts are currently focused in these key domains: Patient Access, Policy/Advocacy, and Provider Training.

 


[i] Trussell, J. “Contraceptive Failure in the United States.” Contraception 83 (2011): 397-404. Access from: http://www.ncbi.nlm.nih.gov/pubmed/21477680

[ii] Grimes, D. “Forgettable Contraception.” Contraception. 80, 6(2009): 497-499. Accessed from: http://www.ncbi.nlm.nih.gov/pubmed/19913141

[iii] ACOG. " ACOG. "Adolescents & Long-Acting Reversible Contraception: Implants and Intrauterine Devices." Committee Opinion No. 405 (2009):. 1-5.5. Accessed from:http://www.acog.org/~/media/Committee%20Opinions/Committee%20on%20Gynecologic%20Practice/co450.pdf?dmc=1&ts=20140303T1553209882